gut microbiota

DNA-damaging microbial metabolites found in people with inflammatory bowel disease

The findings of a recent study suggest that DNA damage-inducing microbial metabolites such as indolimines play a role in the development of colorectal cancer.

Some gut bacteria may trigger autoimmunity in rheumatoid arthritis

The findings of a recent study suggest that a specific strain of Subdoligranulum can drive the production of autoantibodies in rheumatoid arthritis.

Nicotine-degrading microbes may protect against smoking-related liver disease

Scientists identified a bacterium, Bacteroides xylanisolvens, that reduced gut nicotine concentrations in mice exposed to nicotine as well as the severity of NAFLD.

Some gut bacteria can curb atherosclerosis in mice

A recent study provides evidence for the beneficial effects of GMD and the gut commensal bacterium P. merdae against obesity-related atherosclerosis.

Proge Farm receives authorisation for the gynaecological drug containing its Lactobacillus plantarum p 17630 in the EU

Important goal reached by the Novara-based pharmaceuticals company, specialised in the production and marketing of live biotherapeutic products.

Periodontitis may be linked to Alzheimer’s disease

Periodontitis might be associated with cognitive decline, suggesting a possible etiopathologic role in Alzheimer's disease.

Microbiota-derived ethanol may contribute to nonalcoholic fatty liver disease

The findings of a new research suggest that, in some people, microbial ethanol can contribute to the development of NAFLD.

BiomeBank announces world first regulatory approval for donor derived microbiome drug

Formal approval of BiomeBank’s first-generation donor derived microbiome-based therapy product, BIOMICTRA registered in the Australian Register of Therapeutic Goods

L. rhamnosus GG increases Bifidobacteria and reduces inflammation in children with cystic fibrosis, study says

A supplement of LGG would seem to favour the proliferation of Bifidobacterium and the improvement of clinical and immunological response to childhood cystic fibrosis.

Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx

Healthy, diabetic, and obese people compared on diet and lifestyle using innovative technologies and multi-omics analysis

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top